As the world enters a phase of the global pandemic marked by an increasing rate of vaccinations, investors are looking for global (particularly, European) healthcare market opportunities. With the emergence of certain...more
9/9/2021
/ Buyers ,
Capital Markets ,
Coronavirus/COVID-19 ,
EBITDA ,
Environmental Social & Governance (ESG) ,
EU ,
Healthcare ,
Investment ,
Investors ,
Market Infrastructure ,
Private Equity ,
Sellers ,
Take-Private Transactions ,
UK
After the COVID-19 slowdown in 2020, the United Kingdom has been one of the most active buyout markets in Europe, with a 60% rise in buyouts in 2021 compared to 2020.
This increase in activity has been driven in part by a...more
In a climate where there are so many unknown factors challenging valuation methodologies, we explore a number of mechanisms that European dealmakers may consider during the Coronavirus (COVID-19) pandemic in order to bridge...more
12/4/2020
/ Acquisitions ,
Buyers ,
Coronavirus/COVID-19 ,
Deferred Consideration ,
Earn-Outs ,
EBITDA ,
EU ,
Fairness Standard ,
Fixed Price Contracts ,
Global Dealmaking ,
Indemnity Insurance ,
Mergers ,
Sellers ,
Warranty Insurance